What this AI news story is about
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into an initiative to create a "virtual cell" that researchers can use to combat disease, as reported earlier by Reuters. The project is led by Biohub, a nonprofit biomedical research…
What happened
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into an initiative to create a “virtual cell” that researchers can use to combat disease, as reported earlier by Reuters. The project is led by Biohub, a nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan. It comes as part of a $1.8 billion “Virtual Biology” initiative to build AI datasets that could allow researchers to “ask, predict, and answer biological questions digitally.”
Founded in 2016, Biohub aims to prevent and cure diseases through the creation of a “high-accuracy predictive mode …
Read the full story at The Verge.
What readers should know
This TrueVitaHub page summarizes the news information available in the feed. For the complete publisher report, additional reporting, quotes and the latest updates, visit the original source.
Continue with the original source
Read the publisher's complete report for the full story and any subsequent updates.
